KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Invested Capital (2021 - 2025)

Ginkgo Bioworks Holdings' Return on Invested Capital history spans 5 years, with the latest figure at 0.59% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 15.0% year-over-year to 0.59%; the TTM value through Dec 2025 reached 0.59%, up 15.0%, while the annual FY2025 figure was 0.51%, 10.0% up from the prior year.
  • Return on Invested Capital reached 0.59% in Q4 2025 per DNA's latest filing, up from 0.59% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.2% in Q3 2021 to a low of 2.43% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 0.95%, with a median of 0.78% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: tumbled -223bps in 2022, then skyrocketed 177bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 1.15% in 2021, then decreased by -20bps to 1.38% in 2022, then skyrocketed by 47bps to 0.74% in 2023, then decreased by 0bps to 0.74% in 2024, then rose by 20bps to 0.59% in 2025.
  • Per Business Quant, the three most recent readings for DNA's Return on Invested Capital are 0.59% (Q4 2025), 0.59% (Q3 2025), and 0.5% (Q2 2025).